Free Trial

Intra-Cellular Therapies (ITCI) Short Interest Ratio & Short Volume

$65.54
-0.83 (-1.25%)
(As of 05/24/2024 ET)

Intra-Cellular Therapies Short Interest Data

Current Short Interest
3,670,000 shares
Previous Short Interest
3,590,000 shares
Change Vs. Previous Month
+2.23%
Dollar Volume Sold Short
$263.54 million
Short Interest Ratio
3.8 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
105,570,000 shares
Percentage of Shares Shorted
3.48%
Today's Trading Volume
628,393 shares
Average Trading Volume
827,528 shares
Today's Volume Vs. Average
76%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Intra-Cellular Therapies ?

Sign up to receive the latest short interest report for Intra-Cellular Therapies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ITCI Short Interest Over Time

ITCI Days to Cover Over Time

ITCI Percentage of Float Shorted Over Time

Intra-Cellular Therapies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20243,670,000 shares $263.54 million +2.2%N/A3.8 $71.81
4/15/20243,590,000 shares $232.49 million +3.5%N/A3.7 $64.76
3/31/20243,470,000 shares $240.12 million +4.8%N/A4.5 $69.20
3/15/20243,310,000 shares $214.42 million -10.5%N/A4.1 $64.78
2/29/20243,700,000 shares $257.22 million -4.2%N/A4.3 $69.52
2/15/20243,860,000 shares $289.08 million -5.2%N/A4.4 $74.89
1/31/20244,070,000 shares $274.07 million +16.0%N/A4.9 $67.34
1/15/20243,510,000 shares $232.92 million -7.9%N/A3.8 $66.36
12/31/20233,810,000 shares $272.87 million +5.8%N/A4 $71.62
12/15/20233,600,000 shares $235.58 million -8.4%N/A3.9 $65.44
11/30/20233,930,000 shares $241.18 million +15.3%N/A4.5 $61.37
11/15/20233,410,000 shares $193.31 million +7.9%N/A4.1 $56.69
10/31/20233,160,000 shares $157.24 million +17.9%N/A3.9 $49.76
10/15/20232,680,000 shares $143.81 million -4.6%N/A3.9 $53.66
9/30/20232,810,000 shares $146.37 million +26.0%N/A4.3 $52.09
9/15/20232,230,000 shares $122.72 million -12.6%N/A3.5 $55.03
8/31/20232,550,000 shares $141.58 million +0.4%N/A4 $55.52
8/15/20232,540,000 shares $146.86 million +25.1%N/A4 $57.82
7/31/20232,030,000 shares $125.54 million -16.8%N/A3.1 $61.84
7/15/20232,440,000 shares $154.99 million -6.2%N/A3.4 $63.52
6/30/20232,600,000 shares $164.63 million -22.2%N/A3.5 $63.32
6/15/20233,340,000 shares $214.66 million -2.9%N/A4 $64.27
5/31/20233,440,000 shares $204.27 million -3.4%N/A4.2 $59.38
5/15/20233,560,000 shares $231.08 million +21.9%N/A4 $64.91
4/30/20232,920,000 shares $181.48 million -9.6%N/A3.3 $62.15
4/15/20233,230,000 shares $194.48 million -3.0%N/A3.9 $60.21
3/31/20233,330,000 shares $180.32 million +27.6%N/A4.1 $54.15
3/15/20232,610,000 shares $114.32 million -21.2%N/A3.9 $43.80
2/28/20233,310,000 shares $162.29 million +37.9%N/A5 $49.03
2/15/20232,400,000 shares $120 million -8.8%N/A4 $50.00
1/31/20232,630,000 shares $126.03 million +1.5%N/A4.6 $47.92
1/15/20232,590,000 shares $124.40 million -19.3%N/A4.1 $48.03
12/30/20223,210,000 shares $169.87 million +7.4%N/A5.1 $52.92
12/15/20222,990,000 shares $154.97 million +7.2%N/A4.6 $51.83
11/30/20222,790,000 shares $151.27 million -12.3%N/A4.1 $54.22
11/15/20223,180,000 shares $161.10 million -21.7%N/A4.5 $50.66
10/31/20224,060,000 shares $185.42 million +1.0%N/A5.3 $45.67
10/15/20224,020,000 shares $188.82 million -1.5%N/A5.5 $46.97
9/30/20224,080,000 shares $189.84 million +7.4%N/A5.6 $46.53
9/15/20223,800,000 shares $192.01 million +15.5%N/A5.1 $50.53
$1,500 to $9,400 in one month? (A.I. Trade List) (Ad)

This brand new A.I. Machine finds stocks and options trades which have had nearly PERFECT WIN RATES and gains as high as 1729%*

Click here to reserve your free seat
8/31/20223,290,000 shares $165.36 million -12.0%N/A4.4 $50.26
8/15/20223,740,000 shares $196.46 million +12.0%N/A5 $52.53
7/31/20223,340,000 shares $180.76 million -10.0%N/A4.1 $54.12
7/15/20223,710,000 shares $204.98 million +1.6%N/A4.7 $55.25
6/30/20223,650,000 shares $208.34 million +1.7%N/A4.3 $57.08
6/15/20223,590,000 shares $202.94 million +15.1%8.1%4.1 $56.53
5/31/20223,120,000 shares $179.09 million -18.8%N/A3.6 $57.40
5/15/20223,840,000 shares $226.94 million +15.0%N/A4 $59.10
4/30/20223,340,000 shares $169.04 million -12.1%N/A3.5 $50.61
4/15/20223,800,000 shares $244.34 million -1.3%N/A3.8 $64.30
3/31/20223,850,000 shares $235.58 million -10.5%N/A3.7 $61.19
3/15/20224,300,000 shares $250.99 million -11.9%N/A3.3 $58.37
2/28/20224,880,000 shares $270.74 million +1.2%N/A3.9 $55.48
2/15/20224,820,000 shares $269.92 million +1.9%6.6%4 $56.00
1/31/20224,730,000 shares $224.63 million +5.6%6.5%4.3 $47.49
1/15/20224,480,000 shares $192.95 million -1.1%N/A4.3 $43.07
12/31/20214,530,000 shares $237.10 million +22.8%6.2%4.9 $52.34
12/15/20213,690,000 shares $137.30 million +2.2%5.1%5.8 $37.21
11/30/20213,610,000 shares $146.13 million -2.2%5.0%8.1 $40.48
11/15/20213,690,000 shares $148.52 million -12.4%5.1%8.5 $40.25
10/29/20214,210,000 shares $181.32 million -21.2%5.8%9.5 $43.07
10/15/20215,340,000 shares $209.86 million -7.5%7.4%12.6 $39.30
9/30/20215,770,000 shares $215.11 million -1.4%8.0%13.4 $37.28
9/15/20215,850,000 shares $195.80 million No Change8.1%12.2 $33.47
8/31/20215,850,000 shares $194.22 million +7.0%8.1%12.1 $33.20
8/13/20215,470,000 shares $158.79 million -2.5%7.5%11.2 $29.03
7/30/20215,610,000 shares $192.59 million -2.8%7.8%11.3 $34.33
7/15/20215,770,000 shares $216.43 million +11.6%8.0%11.6 $37.51
6/30/20215,170,000 shares $211.04 million -12.2%7.2%10.1 $40.82
6/15/20215,890,000 shares $255.10 million -5.9%8.2%12.3 $43.31
5/28/20216,260,000 shares $246.71 million -8.4%8.7%12.9 $39.41
5/14/20216,830,000 shares $258.58 million No ChangeN/A13 $37.86
4/30/20216,830,000 shares $235.43 million +9.5%N/A12.1 $34.47
4/15/20216,240,000 shares $201.36 million -0.5%N/A10.8 $32.27
3/31/20216,270,000 shares $203.84 million -1.1%N/A10.4 $32.51
3/15/20216,340,000 shares $231.66 million -1.4%N/A9.5 $36.54
2/26/20216,430,000 shares $229.42 million +1.3%N/A9.2 $35.68
2/12/20216,350,000 shares $247.97 million -4.8%N/A8.6 $39.05
1/29/20216,670,000 shares $214.84 million -3.5%N/A8.8 $32.21
1/15/20216,910,000 shares $235.91 million -8.7%N/A9 $34.14
12/31/20207,570,000 shares $243.91 million +11.7%N/A10 $32.22
12/15/20206,780,000 shares $171.33 million +7.8%N/A8.3 $25.27
11/30/20206,290,000 shares $157.12 million +9.0%N/A3.3 $24.98
11/15/20205,770,000 shares $154.46 million +5.5%N/A3.1 $26.77
10/30/20205,470,000 shares $131.17 million -7.3%N/A3 $23.98
10/15/20205,900,000 shares $153.11 million +0.5%N/A3.3 $25.95
9/30/20205,870,000 shares $150.62 million -12.9%N/A3.2 $25.66
9/15/20206,740,000 shares $204.56 million +26.2%N/A3.7 $30.35
8/31/20205,340,000 shares $97.29 million +7.9%N/A3.6 $18.22
8/14/20204,950,000 shares $95.78 million +2.1%N/A6.2 $19.35
$1,500 to $9,400 in one month? (A.I. Trade List) (Ad)

This brand new A.I. Machine finds stocks and options trades which have had nearly PERFECT WIN RATES and gains as high as 1729%*

Click here to reserve your free seat
7/31/20204,850,000 shares $96.18 million -5.1%N/A5.6 $19.83
7/15/20205,110,000 shares $120.75 million -3.8%N/A5.9 $23.63
6/30/20205,310,000 shares $133.71 million +7.7%N/A6.2 $25.18
6/15/20204,930,000 shares $99.34 million +0.2%N/A5.9 $20.15
5/29/20204,920,000 shares $102.73 million -10.2%N/A5.9 $20.88
5/15/20205,480,000 shares $121.05 million +1.7%N/A6.5 $22.09
4/30/20205,390,000 shares $95.24 million +6.5%N/A6.4 $17.67
4/15/20205,060,000 shares $83.24 million No ChangeN/A5.6 $16.45
3/31/20205,060,000 shares $89.82 million +3.9%N/A3.8 $17.75
3/13/20204,869,200 shares $80.20 million +1.9%N/A6 $16.47
2/28/20204,780,000 shares $63.67 million +7.4%N/A1.7 $13.32
2/14/20204,450,000 shares $86.64 million +2.1%N/A1.5 $19.47
1/31/20204,360,000 shares $96.97 million -33.3%9.3%1.5 $22.24
1/15/20206,540,000 shares $142.31 million -21.9%14.0%2.3 $21.76
12/31/20198,370,000 shares $197.62 million -34.9%17.9%3.1 $23.61

ITCI Short Interest - Frequently Asked Questions

What is Intra-Cellular Therapies' current short interest?

Short interest is the volume of Intra-Cellular Therapies shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 3,670,000 shares of ITCI short. Learn More on Intra-Cellular Therapies' current short interest.

What is a good short interest ratio for Intra-Cellular Therapies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ITCI shares currently have a short interest ratio of 4.0. Learn More on Intra-Cellular Therapies's short interest ratio.

Which institutional investors are shorting Intra-Cellular Therapies?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Intra-Cellular Therapies: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, HAP Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Intra-Cellular Therapies' short interest increasing or decreasing?

Intra-Cellular Therapies saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 3,670,000 shares, an increase of 2.2% from the previous total of 3,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Intra-Cellular Therapies' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Intra-Cellular Therapies: Viking Therapeutics, Inc. (10.98%), Ascendis Pharma A/S (6.36%), Jazz Pharmaceuticals plc (5.71%), Cerevel Therapeutics Holdings, Inc. (7.57%), Blueprint Medicines Co. (7.25%), Legend Biotech Co. (7.29%), Cytokinetics, Incorporated (13.51%), Elanco Animal Health Incorporated (2.73%), Organon & Co. (4.71%), BridgeBio Pharma, Inc. (11.52%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Intra-Cellular Therapies stock?

Short selling ITCI is an investing strategy that aims to generate trading profit from Intra-Cellular Therapies as its price is falling. ITCI shares are trading down $0.83 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Intra-Cellular Therapies?

A short squeeze for Intra-Cellular Therapies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ITCI, which in turn drives the price of the stock up even further.

How often is Intra-Cellular Therapies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ITCI, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ITCI) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners